Skip to main content
Content Starts Here GSA Federal Advisory Committee Act (FACA) Database Skip to main content

Committee Detail

Note: An Annual Comprehensive Review, as required by §7 of the Federal Advisory Committee Act, is conducted each year on committee data entered for the previous fiscal year (referred to as the reporting year). The data for the reporting year is not considered verified until this review is complete and the data is moved to history for an agency/department. See the Data From Previous Years section at the bottom of this page for the committee’s historical, verified data.

Details on agency responses to committee recommendations can be found under the Performance Measures section for each committee in the fields “Agency Feedback” and “Agency Feedback Comment.”


HHS - 881 - National Human Genome Research Institute Initial Review Group - Authorized by Law
Hide Section - GENERAL INFORMATION

GENERAL INFORMATION

Committee NameNational Human Genome Research Institute Initial Review GroupAgency NameDepartment of Health and Human Services
Fiscal Year2022Committee Number881
Original Establishment Date11/20/1985Committee StatusChartered
Actual Termination Date Committee URLhttp://www.genome.gov/10000914
New Committee This FYNoPresidential Appointments*No
Terminated This FYNoMax Number of Members*Unlimited
Current Charter Date7/1/1990Designated Fed Officer Position Title*CO-CHIEF, SCIENTIFIC REVIEW BRANCH
Date Of Renewal Charter Designated Federal Officer Prefix
Projected Termination Date Designated Federal Officer First Name*Rudy
Exempt From Renewal*YesDesignated Federal Officer Middle NameO.
Specific Termination AuthorityDesignated Federal Officer Last Name*Pozzatti
Establishment Authority*Authorized by LawDesignated Federal Officer SuffixPHD
Specific Establishment Authority*42 U.S.C. 282(b)(16)Designated Federal Officer Phone*(301) 402-8739
Effective Date Of Authority*11/20/1985Designated Federal Officer Fax*(301) 402-1951
Exempt From EO 13875 Discretionary CmteNot ApplicableDesignated Federal Officer Email*pozzattr@exchange.nih.gov
Committee Type*Continuing
Presidential*No
Committee Function*Grant Review Committee
Hide Section - RECOMMENDATION/JUSTIFICATIONS

RECOMMENDATION/JUSTIFICATIONS

Agency Recommendation*Continue
Legislation to Terminate RequiredNot Applicable
Legislation StatusNot Applicable
How does cmte accomplish its purpose?*Section 492 of the PHS Act states that The Secretary...shall by regulation require appropriate technical and scientific peer review of --(A) applications...; and (B) biomedical and behavioral research and development contracts.... This committee is composed entirely of recognized biomedical and/or behavioral research authorities who represent the forefront of research and technical knowledge and who provide first-level merit review of highly scientific and technical research grant applications (and/or contract proposals) in the areas relevant to genomic research including: construction of genetic maps, development of physical maps, determination of DNA sequences, management and analysis of the resulting data, development of innovative technologies required to achieve the above, and development of tools and resources supportive of this effort, as well as in areas relevant to the ethical, legal, and social implication of genomic research. During this reporting period the committee reviewed 44 applications in the amount of $115,033,880.00.
How is membership balanced?*The members of this committee are authorities knowledgeable in the fields of biologic informatics, software design of genetic information systems, molecular cytogenetics, human gene mapping, gene transfer, gene therapy, physical mapping, comparative genetics, genetic mapping, population genetics, epidemiology, developmental biology, informatics, sequencing, instrumentation computer analysis, chemistry and cytogenetics, and the ethical, legal, and social implications of human genome research.
How frequent & relevant are cmte mtgs?*The committee conducted three FACA meetings during this reporting period on the following dates: 11/04-05/2021, 03/03/2022, and 06/02/2022.
Why advice can't be obtained elsewhere?*This committee is composed entirely of recognized biomedical and/or behavioral research authorities who represent the forefront of research and technical knowledge and who provide first-level merit review of highly scientific and technical research grant applications and contract proposals. These evaluations and recommendations cannot be obtained from other sources because the specialized, complex nature of the applications and proposals requires a unique balance and breadth of expertise not available on the NIH staff or from established sources.
Why close or partially close meetings?The meetings of the National Human Genome Research Institute Initial Review Group were closed to the public for the review of grant applications and/or contract proposals. Sections 552b(c)(4) and 552b(c)(6) of the Government in the Sunshine Act permit the closing of meetings where discussion could reveal confidential trade secrets or commercial property such as patentable material and personal information, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.
Recommendation RemarksReports: This committee did not produce any public reports during the fiscal year.

The DFO and Decision Maker are the same person, the Co-Chief, Scientific Review Branch due to delegations of authority and assignments in this Institute.

Dr. Rudy Pozzatti replaced Dr. Nakamura as DFO and Decision maker when Dr. Nakamura retired December 2021.

Meetings were held virtually in FY22 due to the ongoing COVID-19 pandemic.

Dr. Hector Corrada Bravo was reappointed for serve from 07/01/2021 to 6/30/2022.

Dr. Mark Adams was inadvertently left off the 2021 report. His term dates are July 1, 2021 until June 30, 2025.

Dr. Rahul Satija was inadvertently left off the 2021 report. His term dates are July 1, 2021 until June 30, 2025.

Dr. Chunhua Weng term was incorrectly listed on the 2021 report. His term dates are July 1, 2021 until June 30, 2025.

Dr. Barbara Stranger's Appointment Start Date was incorrectly listed as January 13, 2020 in previous reports. The correct start date is January 30, 2020.

The 2021 report did not include a statement that Dr. Timothy Thorton resigned from the committee on March 25, 2021.
Hide Section - PERFORMANCE MEASURES

PERFORMANCE MEASURES

Outcome Improvement To Health Or Safety*NoAction Reorganize Priorities*No
Outcome Trust In GovernmentNoAction Reallocate ResourcesNo
Outcome Major Policy ChangesNoAction Issued New RegulationsNo
Outcome Advance In Scientific ResearchYesAction Proposed LegislationNo
Outcome Effective Grant MakingYesAction Approved Grants Or Other PaymentsYes
Outcome Improved Service DeliveryNoAction OtherNo
Outcome Increased Customer SatisfactionNoAction CommentAn action of “approved” or “recommended” for grants receiving initial peer review by this committee does not infer that the grant will be or has been funded. Research grant applications submitted to NIH must go through a two-step review process that includes the initial peer review for scientific and technical merit and a second step of review and approval by a National Advisory Council for program relevance. In addition, prior to an award or funding being made, NIH staff must conduct an administrative review for a number of other considerations. These include alignment with NIH’s funding principles, review of the project budget, assessment of the applicant’s management systems, determination of applicant eligibility, and compliance with public policy requirements. After all these steps have been completed, NIH officials make funding decisions on individual grant applications.
Outcome Implement Laws/Reg RequirementsNoGrants Review*Yes
Outcome OtherNoNumber Of Grants Reviewed44
Outcome CommentN/ANumber Of Grants Recommended44
Cost Savings*Unable to DetermineDollar Value Of Grants Recommended$115,033,880.00
Cost Savings CommentNIH supported basic and clinical research accomplishments often take many years to unfold into new diagnostic tests and new ways to treat and prevent diseases.Grants Review CommentNA
Number Of Recommendations*649Access Contact Designated Fed. Officer*Yes
Number Of Recommendations CommentGrant reviewAccess Agency WebsiteYes
% of Recs Fully Implemented*0.00%Access Committee WebsiteYes
% of Recs Fully Implemented CommentNIH Peer Review Committees are involved in the initial review of research grant applications. The NIH dual peer review system is mandated by statute in accordance with section 492 of the Public Health Service Act. The charge to this committee is to determine scientific and technical merit of the individual grants or contracts. These recommendations are forwarded to Federal officials who generally accept the committee’s recommendations and favorable applications are then forwarded for the second level of review performed by Institute and Center (IC) National Advisory Councils or Boards. Only applications that are favorably recommended by both the initial peer review committee and the Advisory Council may be recommended for funding.Access GSA FACA WebsiteYes
% of Recs Partially Implemented*0.00%Access PublicationsNo
% of Recs Partially Implemented CommentNIH Peer Review Committees are involved in the initial review of research grant applications. The NIH dual peer review system is mandated by statute in accordance with section 492 of the Public Health Service Act. The charge to this committee is to determine scientific and technical merit of the individual grants or contracts. These recommendations are forwarded to Federal officials who generally accept the committee’s recommendations and favorable applications are then forwarded for the second level of review performed by Institute and Center (IC) National Advisory Councils or Boards. Only applications that are favorably recommended by both the initial peer review committee and the Advisory Council may be recommended for funding.Access OtherYes
Agency Feedback*YesAccess CommentIC Committee Management Officer 240-669-5201
Agency Feedback Comment*Information resulting from closed initial peer review meetings is subject to the Freedom of Information Act. The public can view information on research projects funded by NIH on the RePORT (Research Portfolio Online Reporting Tool) website located at http://report.nih.gov.Narrative Description*The goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold. The NIH mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by supporting the research of non-Federal scientists in universities, medical schools, hospitals, and research institutions throughout the country and abroad. Section 492 of the PHS Act states that The Secretary ...shall by regulation require appropriate technical and scientific peer review of -(A) applications...; and (B) biomedical and behavioral research and development contracts...
Hide Section - COSTS

COSTS

Payments to Non-Federal Members*$11,200.00Est Payments to Non-Fed Members Next FY*$11,200.00
Payments to Federal Members*$0.00Est. Payments to Fed Members Next FY*$0.00
Payments to Federal Staff*$141,618.00Estimated Payments to Federal Staff*$140,911.00
Payments to Consultants*$0.00Est. Payments to Consultants Next FY*$0.00
Travel Reimb. For Non-Federal Members*$0.00Est Travel Reimb Non-Fed Members nextFY*$11,448.00
Travel Reimb. For Federal Members*$0.00Est Travel Reimb For Fed Members*$0.00
Travel Reimb. For Federal Staff*$0.00Est. Travel Reimb to Fed Staff Next FY*$0.00
Travel Reimb. For Consultants*$0.00Est Travel Reimb to Consultants Next FY*$0.00
Other Costs$0.00Est. Other Costs Next FY*$6,356.00
Total Costs$152,818.00Est. Total Next FY*$169,915.00
Date Cost Last Modified9/16/2022 3:36 PMEst. Fed Staff Support Next FY*0.90
Federal Staff Support (FTE)*0.90Est Cost RemarksProjected costs for FY23 were increased in the event that in-person/hybrid meetings resume.

Projected Federal staff costs for FY2023 are lower due to the retirement of the DFO, Dr. Ken Nakamura in December 2021.
Cost RemarksMeetings were held virtually in FY22 due to the ongoing COVID-19 pandemic.

Federal staff costs decreased from FY2021 to FY2022 due to the retirement of the DFO, Dr. Ken Nakamura in December 2021.
  
Hide Section - Interest Areas

Interest Areas

Category
Area
Health
Health Care
Medicine
Health and Health Research
Hide Section - MEMBERS,MEETINGS AND ADVISORY REPORTS

MEMBERS,MEETINGS AND ADVISORY REPORTS

To View all the members, meetings and advisory reports for this committee please click here
Hide Section - CHARTERS AND RELATED DOCS

CHARTERS AND RELATED DOCS

No Documents Found
Hide Section - DATA FROM PREVIOUS YEARS

DATA FROM PREVIOUS YEARS

Committee

Data from Previous Years

 
ActionCommittee System IDCommittee NameFiscal Year
 COM-040425National Human Genome Research Institute Initial Review Group2021
 COM-038700National Human Genome Research Institute Initial Review Group2020
 COM-036574National Human Genome Research Institute Initial Review Group2019
 COM-034782National Human Genome Research Institute Initial Review Group2018
 COM-002018National Human Genome Research Institute Initial Review Group2017
 COM-002412National Human Genome Research Institute Initial Review Group2016
 COM-003812National Human Genome Research Institute Initial Review Group2015
 COM-004456National Human Genome Research Institute Initial Review Group2014
 COM-006236National Human Genome Research Institute Initial Review Group2013
 COM-006937National Human Genome Research Institute Initial Review Group2012
 COM-008381National Human Genome Research Institute Initial Review Group2011
 COM-008714National Human Genome Research Institute Initial Review Group2010
 COM-010076National Human Genome Research Institute Initial Review Group2009
 COM-011014National Human Genome Research Institute Initial Review Group2008
 COM-012126National Human Genome Research Institute Initial Review Group2007
 COM-012680National Human Genome Research Institute Initial Review Group2006
 COM-013746National Human Genome Research Institute Initial Review Group2005
 COM-014541National Human Genome Research Institute Initial Review Group2004
 COM-016031National Human Genome Research Institute Initial Review Group2003
 COM-016579National Human Genome Research Institute Initial Review Group2002
 COM-017988National Human Genome Research Institute Initial Review Group2001
 COM-018375National Human Genome Research Institute Initial Review Group2000
 COM-019782National Human Genome Research Institute Initial Review Group1999
 COM-020315National Human Genome Research Institute Initial Review Group1998
 COM-021515National Human Genome Research Institute Initial Review Group1997